Enhancement of the SOD levels in the CCR group at weeks 81/82 may also contribute to the reduced tumor incidence rate in this group, since increased SOD activity has been linked to cancer prevention, including breast cancer [34]. This evidence concerns the gene SOD1 and breast carcinoma.